These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8402519)

  • 1. Ethical and financial considerations in third-party support of investigational cancer therapies.
    Young FE
    Cancer; 1993 Nov; 72(9 Suppl):2854-8. PubMed ID: 8402519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reimbursement issues facing patients, providers, and payers.
    Antman K
    Cancer; 1993 Nov; 72(9 Suppl):2842-5. PubMed ID: 8402516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 4. The crisis in clinical cancer research. Third-party insurance and investigational therapy.
    Antman K; Schnipper LE; Frei E
    N Engl J Med; 1988 Jul; 319(1):46-8. PubMed ID: 3288868
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs with breakthrough status charm investors.
    Senior M
    Nat Biotechnol; 2013 Nov; 31(11):945-7. PubMed ID: 24213748
    [No Abstract]   [Full Text] [Related]  

  • 6. Market watch: Upcoming market catalysts in Q3 2016.
    Ranj T
    Nat Rev Drug Discov; 2016 Jul; 15(7):449. PubMed ID: 27282354
    [No Abstract]   [Full Text] [Related]  

  • 7. Balancing safety, effectiveness, and public desire: the FDA and cancer.
    Conti R
    Issue Brief (Commonw Fund); 2003 Apr; (615):1-6. PubMed ID: 12693391
    [No Abstract]   [Full Text] [Related]  

  • 8. Institute of Medicine, Congress seek solutions to FDA's safety woes through reform, funding.
    Finkelstein JB
    J Natl Cancer Inst; 2007 Jan; 99(2):104-7. PubMed ID: 17227990
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing oncology research protocols.
    Lunik MC
    Top Hosp Pharm Manage; 1994 Jul; 14(2):11-21. PubMed ID: 10136201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
    Huber SL
    Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reimbursement of biotherapy: present status, future directions--perspectives of the hospital-based oncology nurse.
    McCabe MS
    Semin Oncol Nurs; 1992 Nov; 8(4 Suppl 1):3-7. PubMed ID: 1462056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitals try to devise solutions in device debate.
    Scott L
    Mod Healthc; 1995 Feb; 25(8):34-6, 38. PubMed ID: 10140204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug pipeline: 3Q15.
    DeFrancesco L
    Nat Biotechnol; 2015 Nov; 33(11):1126. PubMed ID: 26544135
    [No Abstract]   [Full Text] [Related]  

  • 15. Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007.
    Meron D
    Seton Hall Law Rev; 2007; 37(4):929-39. PubMed ID: 18363219
    [No Abstract]   [Full Text] [Related]  

  • 16. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 17. Expanded access to investigational drugs for treatment use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should insurance be responsible for the cost of care while a patient is enrolled in a clinical trial?
    Weiss PA
    Clin J Oncol Nurs; 2008 Feb; 12(1):153-4. PubMed ID: 18258585
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers left to guess at outcomes of most cancer clinical trials.
    Twombly R
    J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
    [No Abstract]   [Full Text] [Related]  

  • 20. Support for trials of promising medications through the Pharmaceutical Benefits Scheme.
    Bell KD
    Med J Aust; 1995 Apr; 162(8):447; author reply 447-8. PubMed ID: 7746194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.